Scouting and opportunity assessment
S&P · Business Development & Transactions
Transactions create value only when assumptions and implementation fit.
S&P supports life sciences organizations and investors in assessing opportunities, risks, and strategic fit. We connect scientific, medical, and commercial perspectives with business planning and organizational feasibility.
Business Development & Transactions
Transaction and partnering scope
Partnering, licensing in, and licensing out
Commercial and strategic due diligence
Business case, scenarios, and sensitivity analysis
Negotiation, contracting, and governance support
Integration, co development, and co commercialization logic
Assess value creation and de-risking together
High unmet medical need may justify exploration, but only validated feasibility justifies the next commitment of capital.
Medical value, scientific evidence, protected innovation, differentiation, stakeholder acceptance, and execution capability must converge in one risk-adjusted assessment.
What the figure means for management
Enthusiasm for an asset is translated into explicit, testable assumptions. The assessment shows where evidence is strong, where risk remains hidden, and where management can still change the outcome.
Concrete S&P contribution
S&P assesses strategic fit, business case, evidential strength, risk, resources, and integration logic and focuses due diligence on uncertainties that can still be reduced.
Business Development & TransactionsAssess an opportunity or transaction
Integrated management assessment
S&P does not provide legal, tax, or specialized technical due diligence. We integrate these contributions into the strategic and commercial assessment and make their management implications visible.